EVERSANA Announces European Expansion
EVERSANA, a provider of next generation commercial services to the global life sciences industry, has opened a new office in London, UK to serve the company’s growing client and team needs.
Mike Ryan, Executive Vice President, EMEA, will be based at the London office, which includes experts across the company’s commercialization solutions.
Jim Lang, CEO, commented, “It’s our privilege to work with our clients across Europe—a region that continues to bring new innovations to market every day. Our teams have operated from Europe for many decades. As our world begins to come together in person once again, our London location is all about collaboration with each other and those we serve.”
The new location further accelerates EVERSANA’s position across Europe, which includes employees in 18 countries. The company has announced multiple commercialization agreements with European-based partners and clients. In 2021, the company also announced the expansion of medical information and integrated compliance services across Europe.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
